par Rolfo, Christian;Manca, Paolo;Salgado, Roberto;Van Dam, Peter;Dendooven, Amelie;Machado Coelho, Andreia;Ferri Gandia, Jose;Rutten, Annemie;Lybaert, Willem;Vermeij, Joanna;Gevaert, Thomas;Weyn, Christine ;Lefebure, Anneke;Metsu, Sofie;Van Laere, Steven;Peeters, Marc ;Pauwels, Patrick
Référence ESMO Open, 3, 5, page (e000398)
Publication Publié, 2018
Référence ESMO Open, 3, 5, page (e000398)
Publication Publié, 2018
Article révisé par les pairs
Résumé : | The complexity of delivering precision medicine to oncology patients has led to the creation of molecular tumourboards (MTBs) for patient selection and assessment of treatment options. New technologies like the liquid biopsy are augmenting available therapeutic opportunities. This report aims to analyse the experience of our MTB in the implementation of personalised medicine in a cancer network. |